Last reviewed · How we verify

NCT04548882

Calypso Knee System Clinical Sub-study, OUS Continued Evaluation

Withdrawn NA Last updated 8 November 2021
What this trial tests

NA trial testing Calypso Knee System in Osteoarthritis, Knee. Withdrawn.

Timeline
11 September 2020
Primary endpoint
12 October 2021
12 October 2021

Quick facts

Lead sponsorMoximed
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date11 September 2020
Primary completion12 October 2021
Estimated completion12 October 2021

Drugs / interventions tested

Conditions studied

Sponsor

Moximed

Who can join

Adults 25 to 65, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Calypso Knee System Clinical Study, OUS for subjects with symptomatic osteoarthritis of the medial compartment of the knee. The sub-study will achieve continued evaluation of the safety and clinical effectiveness of the Calypso Knee System.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Moximed trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04548882.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing